Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Other Operating Expenses (2016 - 2026)

Champions Oncology has reported Other Operating Expenses over the past 17 years, most recently at $11.6 million for Q1 2026.

  • Quarterly results put Other Operating Expenses at $11.6 million for Q1 2026, up 37.59% from a year ago — trailing twelve months through Jan 2026 was $40.6 million (up 13.34% YoY), and the annual figure for FY2025 was $36.2 million, down 1.82%.
  • Other Operating Expenses for Q1 2026 was $11.6 million at Champions Oncology, up from $9.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for CSBR hit a ceiling of $11.6 million in Q1 2026 and a floor of $7.8 million in Q2 2022.
  • Median Other Operating Expenses over the past 5 years was $9.3 million (2025), compared with a mean of $9.2 million.
  • Biggest five-year swings in Other Operating Expenses: dropped 12.68% in 2025 and later skyrocketed 37.59% in 2026.
  • Champions Oncology's Other Operating Expenses stood at $9.1 million in 2022, then fell by 7.98% to $8.4 million in 2023, then grew by 9.1% to $9.2 million in 2024, then grew by 0.88% to $9.3 million in 2025, then rose by 25.15% to $11.6 million in 2026.
  • The last three reported values for Other Operating Expenses were $11.6 million (Q1 2026), $9.3 million (Q4 2025), and $9.9 million (Q3 2025) per Business Quant data.